Regulations.gov document
Attachment 2- Federal Register Notice that Azo Gantanol and Azo Gantrisin were not…
Supporting & Related Material · FDA-2019-P-5791 · posted Dec 9, 2019
Key facts
| Document ID | FDA-2019-P-5791-0004 |
|---|---|
| Title | Attachment 2- Federal Register Notice that Azo Gantanol and Azo Gantrisin were not withdrawn from sale for reason of safety or effectiveness RE Citizen Petition from Guvam Pharma LLC |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2019-P-5791 |
| Posted | Dec 9, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: